Rxcurve
HCPCS J9048 · per 0.1 MG

Inj, bortezomib freseniuskab

This code is not in the latest file (4Q26). It was last listed in 1Q23.

Payment limit per 0.1 MG, by effective quarter, 1Q23 to 1Q23. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9048

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
1Q23 $2.677 – 0.1 MG Inj, bortezomib freseniuskab v1, posted December 6, 2023

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files